Optimized Ribociclib nanostructured lipid carrier for the amelioration of skin cancer: Inferences from ex-vivo skin permeation and dermatokinetic studies
-
Published:2024-03
Issue:3
Volume:32
Page:101984
-
ISSN:1319-0164
-
Container-title:Saudi Pharmaceutical Journal
-
language:en
-
Short-container-title:Saudi Pharmaceutical Journal
Author:
Aldawsari Mohammed F.,
Kamal Mohammad Azhar,
Balaha Mohamed F.,
Jawaid Talha,
Jafar MohammedORCID,
Hashmi Sana,
Ganaie Majid Ahmad,
Alam Aftab
Reference60 articles.
1. Natural agents: Cellular and molecular mechanisms of photoprotection;Afaq;Arch. Biochem. Biophys.,2011
2. Ribociclib-loaded ethylcellulose-based nanosponges: formulation, physicochemical characterization, and cytotoxic potential against breast cancer;Ahmed;Adsorp. Sci. Tech.,2022
3. Adaptation of quality by design-based development of isradipine nanostructured-lipid carrier and its evaluation for in vitro gut permeation and in vivo solubilization fate;Alam;J. Pharm. Sci.,2018
4. Statistically optimized tacrolimus and thymoquinone co-loaded nanostructured lipid carriers gel for improved topical treatment of psoriasis;Alam;Gels,2023
5. Nanostructured lipid carrier-based codelivery of raloxifene and naringin: formulation, optimization, in vitro, ex vivo, in vivo assessment, and acute toxicity studies;Alhalmi;Pharmaceutics,2022